drugset / Trial / NCT01708707
Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the study is to determine whether buprenorphine is a beneficial, safe, cost effective treatment alternative to morphine sulfate in the treatment of Neonatal Abstinence Syndrome (NAS).
Timeline
- Start
- 2012-12
- Primary completion
- 2017-10
- Completion
- 2017-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | 15.9 ug/kg | Other |
| Comparator | Morphine | Other / unclassified | 0.4 mg/kg | Oral |